Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities

Baptiste A.J. Poursat, Rob J.M. van Spanning, Martin Braster, Rick Helmus, Pim de Voogt, John R. Parsons

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Metformin (MET) is a pharmaceutical product mostly biotransformed in the environment to a transformation product, guanylurea (GUA). In ready biodegradability tests (RBTs), however, contrasting results have been observed for metformin. The objective of this study was to measure the biodegradation of MET and GUA in RBTs, using activated sludge from the local wastewater treatment plant, either directly or after pre-exposure to MET, in a chemostat. The activated sludge community was cultivated in chemostats, in presence or absence of MET, for a period of nine months, and was used in RBT after one, three and nine months. The results of this study showed that the original activated sludge was able to completely remove MET (15 mg/l) and the newly produced GUA (50% of C0MET) under the test conditions. Inoculation of the chemostat led to a rapid shift in the community composition and abundance. The community exposed to 1.5 mg/l of MET was still able to completely consume MET in the RBTs after one-month exposure, but three- and nine-months exposure resulted in reduced removal of MET in the RBTs. The ability of the activated sludge community to degrade MET and GUA is the result of environmental exposure to these chemicals as well as of conditions that could not be reproduced in the laboratory system. A MET-degrading strain belonging to the genus Aminobacter has been isolated from the chemostat community. This strain was able to completely consume 15 mg/l of MET within three days in the test. However, community analysis revealed that the fluctuation in relative abundance of this genus (<1%) could not be correlated to the fluctuation in biodegradation capacity of the chemostat community.

Original languageEnglish
Article number109414
Pages (from-to)1-10
Number of pages10
JournalEcotoxicology and Environmental Safety
Volume182
DOIs
Publication statusPublished - 30 Oct 2019

Fingerprint

Chemostats
Metformin
Biodegradability
Biodegradation
Sewage
Wastewater treatment
Drug products
Chemical analysis
Environmental Exposure
Waste Water

Keywords

  • Biodegradation
  • Chemostat systems
  • Guanylurea
  • Metformin
  • Microbial adaptation
  • Microbial community

Cite this

@article{48353ab98ed848179c025b3122356dc9,
title = "Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities",
abstract = "Metformin (MET) is a pharmaceutical product mostly biotransformed in the environment to a transformation product, guanylurea (GUA). In ready biodegradability tests (RBTs), however, contrasting results have been observed for metformin. The objective of this study was to measure the biodegradation of MET and GUA in RBTs, using activated sludge from the local wastewater treatment plant, either directly or after pre-exposure to MET, in a chemostat. The activated sludge community was cultivated in chemostats, in presence or absence of MET, for a period of nine months, and was used in RBT after one, three and nine months. The results of this study showed that the original activated sludge was able to completely remove MET (15 mg/l) and the newly produced GUA (50{\%} of C0MET) under the test conditions. Inoculation of the chemostat led to a rapid shift in the community composition and abundance. The community exposed to 1.5 mg/l of MET was still able to completely consume MET in the RBTs after one-month exposure, but three- and nine-months exposure resulted in reduced removal of MET in the RBTs. The ability of the activated sludge community to degrade MET and GUA is the result of environmental exposure to these chemicals as well as of conditions that could not be reproduced in the laboratory system. A MET-degrading strain belonging to the genus Aminobacter has been isolated from the chemostat community. This strain was able to completely consume 15 mg/l of MET within three days in the test. However, community analysis revealed that the fluctuation in relative abundance of this genus (<1{\%}) could not be correlated to the fluctuation in biodegradation capacity of the chemostat community.",
keywords = "Biodegradation, Chemostat systems, Guanylurea, Metformin, Microbial adaptation, Microbial community",
author = "Poursat, {Baptiste A.J.} and {van Spanning}, {Rob J.M.} and Martin Braster and Rick Helmus and {de Voogt}, Pim and Parsons, {John R.}",
year = "2019",
month = "10",
day = "30",
doi = "10.1016/j.ecoenv.2019.109414",
language = "English",
volume = "182",
pages = "1--10",
journal = "Ecotoxicology and Environmental Safety",
issn = "0147-6513",
publisher = "Academic Press Inc.",

}

Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities. / Poursat, Baptiste A.J.; van Spanning, Rob J.M.; Braster, Martin; Helmus, Rick; de Voogt, Pim; Parsons, John R.

In: Ecotoxicology and Environmental Safety, Vol. 182, 109414, 30.10.2019, p. 1-10.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities

AU - Poursat, Baptiste A.J.

AU - van Spanning, Rob J.M.

AU - Braster, Martin

AU - Helmus, Rick

AU - de Voogt, Pim

AU - Parsons, John R.

PY - 2019/10/30

Y1 - 2019/10/30

N2 - Metformin (MET) is a pharmaceutical product mostly biotransformed in the environment to a transformation product, guanylurea (GUA). In ready biodegradability tests (RBTs), however, contrasting results have been observed for metformin. The objective of this study was to measure the biodegradation of MET and GUA in RBTs, using activated sludge from the local wastewater treatment plant, either directly or after pre-exposure to MET, in a chemostat. The activated sludge community was cultivated in chemostats, in presence or absence of MET, for a period of nine months, and was used in RBT after one, three and nine months. The results of this study showed that the original activated sludge was able to completely remove MET (15 mg/l) and the newly produced GUA (50% of C0MET) under the test conditions. Inoculation of the chemostat led to a rapid shift in the community composition and abundance. The community exposed to 1.5 mg/l of MET was still able to completely consume MET in the RBTs after one-month exposure, but three- and nine-months exposure resulted in reduced removal of MET in the RBTs. The ability of the activated sludge community to degrade MET and GUA is the result of environmental exposure to these chemicals as well as of conditions that could not be reproduced in the laboratory system. A MET-degrading strain belonging to the genus Aminobacter has been isolated from the chemostat community. This strain was able to completely consume 15 mg/l of MET within three days in the test. However, community analysis revealed that the fluctuation in relative abundance of this genus (<1%) could not be correlated to the fluctuation in biodegradation capacity of the chemostat community.

AB - Metformin (MET) is a pharmaceutical product mostly biotransformed in the environment to a transformation product, guanylurea (GUA). In ready biodegradability tests (RBTs), however, contrasting results have been observed for metformin. The objective of this study was to measure the biodegradation of MET and GUA in RBTs, using activated sludge from the local wastewater treatment plant, either directly or after pre-exposure to MET, in a chemostat. The activated sludge community was cultivated in chemostats, in presence or absence of MET, for a period of nine months, and was used in RBT after one, three and nine months. The results of this study showed that the original activated sludge was able to completely remove MET (15 mg/l) and the newly produced GUA (50% of C0MET) under the test conditions. Inoculation of the chemostat led to a rapid shift in the community composition and abundance. The community exposed to 1.5 mg/l of MET was still able to completely consume MET in the RBTs after one-month exposure, but three- and nine-months exposure resulted in reduced removal of MET in the RBTs. The ability of the activated sludge community to degrade MET and GUA is the result of environmental exposure to these chemicals as well as of conditions that could not be reproduced in the laboratory system. A MET-degrading strain belonging to the genus Aminobacter has been isolated from the chemostat community. This strain was able to completely consume 15 mg/l of MET within three days in the test. However, community analysis revealed that the fluctuation in relative abundance of this genus (<1%) could not be correlated to the fluctuation in biodegradation capacity of the chemostat community.

KW - Biodegradation

KW - Chemostat systems

KW - Guanylurea

KW - Metformin

KW - Microbial adaptation

KW - Microbial community

UR - http://www.scopus.com/inward/record.url?scp=85068497384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068497384&partnerID=8YFLogxK

U2 - 10.1016/j.ecoenv.2019.109414

DO - 10.1016/j.ecoenv.2019.109414

M3 - Article

VL - 182

SP - 1

EP - 10

JO - Ecotoxicology and Environmental Safety

JF - Ecotoxicology and Environmental Safety

SN - 0147-6513

M1 - 109414

ER -